Work

Use of supportive measures to improve outcome and decrease toxicity in docetaxel-based antiangiogenesis combinations in metastatic castrate resistant prostate cancer (mCRPC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e16017

Authors: Fatima H. Karzai, Ravi Amrit Madan, Andrea Borghese Apolo, Yangmin M. Ning, Howard L. Parnes, Philip M. Arlen, Melony A. Beatson, Nancy Harold, Anna Couvillon, John Joseph Wright, Clara Chen, Nancy Ann Dawson, James L. Gulley, William Douglas Figg, William L. Dahut

Institutions: National Cancer Institute, National Institutes of Health, United States Food and Drug Administration, National Institutes of Health Clinical Center, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2604937445

Cites:

Cited by: 1

Related to: 10